1. Home
  2. FNUC vs COCP Comparison

FNUC vs COCP Comparison

Compare FNUC & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frontier Nuclear and Minerals Inc. Common Shares

FNUC

Frontier Nuclear and Minerals Inc. Common Shares

HOLD

Current Price

$0.37

Market Cap

23.9M

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

SELL

Current Price

$0.92

Market Cap

19.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FNUC
COCP
Founded
2018
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.9M
19.2M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
FNUC
COCP
Price
$0.37
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
★ 204.1K
24.6K
Earning Date
12-01-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.65
EPS
★ N/A
N/A
Revenue
N/A
★ $12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$0.76
52 Week High
$2.82
$2.03

Technical Indicators

Market Signals
Indicator
FNUC
COCP
Relative Strength Index (RSI) 21.06 37.08
Support Level N/A $0.76
Resistance Level $0.81 $1.12
Average True Range (ATR) 0.07 0.07
MACD -0.01 -0.01
Stochastic Oscillator 1.64 4.31

Price Performance

Historical Comparison
FNUC
COCP

About FNUC Frontier Nuclear and Minerals Inc. Common Shares

Frontier Nuclear and Minerals Inc is developing a U.S.-focused front-end nuclear fuel cycle company through a portfolio of U.S. uranium exploration and development projects in Wyoming, Colorado, and Utah, together with investments in next-generation uranium enrichment and small modular reactors. Frontier Nuclear is actively evaluating value-accretive investment opportunities in other sectors of the domestic U.S. nuclear fuel cycle. The group is developing a portfolio of critical minerals projects in America, Canada, and Namibia, including uranium, tantalum, cesium, and lithium. Its projects are Engo Valley, Pine Ridge, Shatford Lake, Snow Lake Lithium, and Tallahassee.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: